We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.8%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$83B
AUM Growth
+$4.08B
(+5.2%)
Cap. Flow
-$2.07B
Cap. Flow
% of AUM
-2.5%
Top 10 Holdings %
Top 10 Hldgs %
13.18%
Holding
730
New
59
Increased
161
Reduced
398
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Keurig Dr Pepper
KDP
|
+$550M |
| 2 |
Fidelity National Information Services
FIS
|
+$353M |
| 3 |
Global Payments
GPN
|
+$263M |
| 4 |
CVS Health
CVS
|
+$175M |
| 5 |
Devon Energy
DVN
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$433M |
| 2 |
Lowe's Companies
LOW
|
+$277M |
| 3 |
Oracle
ORCL
|
+$226M |
| 4 |
Progressive
PGR
|
+$220M |
| 5 |
Las Vegas Sands
LVS
|
+$167M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.96% |
| 2 | Healthcare | 15.3% |
| 3 | Industrials | 15.12% |
| 4 | Technology | 14.91% |
| 5 | Consumer Discretionary | 11.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Kelly Services Class A
KELYA
$545M
| $701K | ﹤0.01% |
41,806
| – | – |
|
577
Pacira BioSciences
PCRX
$1.04B
| $698K | ﹤0.01% |
+11,594
| New | +$639K |
|
|
MPT
578
Medical Properties Trust
MPT
$2.86B
| $695K | ﹤0.01% |
29,395
| – | – |
|
579
Dolby
DLB
$4.85B
| $690K | ﹤0.01% |
7,249
| – | – |
|
580
Box
BOX
$4.18B
| $683K | ﹤0.01% |
26,077
-6,002
| -19% | -$155K |
|
581
NWPX Infrastructure Inc
NWPX
$1.24B
| $671K | ﹤0.01% |
21,112
-1,459
| -6% | -$40.2K |
|
|
QIPT
582
DELISTED
Quipt Home Medical
QIPT
| $669K | ﹤0.01% |
119,337
+26,338
| +28% | +$154K |
|
|
LADR
583
Ladder Capital
LADR
$1.24B
| $663K | ﹤0.01% |
55,330
| – | – |
|
584
Hooker Furnishings Corp
HOFT
$149M
| $660K | ﹤0.01% |
28,341
+4,061
| +17% | +$102K |
|
585
Ooma
OOMA
$571M
| $647K | ﹤0.01% |
31,639
+8,106
| +34% | +$165K |
|
586
Radcom
RDCM
$222M
| $646K | ﹤0.01% |
49,480
+6,719
| +16% | +$76.7K |
|
|
ESTE
587
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $633K | ﹤0.01% |
57,834
+25,958
| +81% | +$277K |
|
|
ATRS
588
DELISTED
Antares Pharma, Inc.
ATRS
| $631K | ﹤0.01% |
176,862
+59,488
| +51% | +$208K |
|
589
Motorcar Parts of America
MPAA
$264M
| $626K | ﹤0.01% |
36,693
+7,919
| +28% | +$149K |
|
|
PRFT
590
DELISTED
Perficient Inc
PRFT
| $626K | ﹤0.01% |
4,845
-8,128
| -63% | -$1.07M |
|
|
GPMT
591
Granite Point Mortgage Trust
GPMT
$62.8M
| $610K | ﹤0.01% |
52,128
| – | – |
|
592
CF Industries
CF
$18.4B
| $606K | ﹤0.01% |
8,560
-28,778
| -77% | -$1.8M |
|
|
TGP
593
DELISTED
Teekay LNG Partners L.P.
TGP
| $606K | ﹤0.01% |
35,801
| – | – |
|
594
Avista
AVA
$3.43B
| $587K | ﹤0.01% |
13,824
| – | – |
|
595
Rio Tinto
RIO
$150B
| $582K | ﹤0.01% |
8,693
| – | – |
|
596
International Money Express
IMXI
$386M
| $572K | ﹤0.01% |
35,853
+2,226
| +7% | +$36.1K |
|
597
Arthur J. Gallagher & Co
AJG
$65.1B
| $571K | ﹤0.01% |
3,365
-1,479
| -31% | -$242K |
|
598
Akamai
AKAM
$16.4B
| $567K | ﹤0.01% |
4,845
| – | – |
|
|
VNTR
599
DELISTED
Venator Materials PLC
VNTR
| $567K | ﹤0.01% |
223,412
+57,427
| +35% | +$165K |
|
|
USAK
600
DELISTED
USA Truck Inc
USAK
| $562K | ﹤0.01% |
28,287
-40,188
| -59% | -$764K |
|
Similar funds
Boston Partners's Q4 2021 Portfolio in Review
As of Q4 2021, Boston Partners held 730 positions worth $83B, up 5.2% from $78.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Boston Partners's Q4 2021 filing shows 59 new, 161 increased, 398 reduced and 45 closed positions. Its largest new stake was Keurig Dr Pepper: 15,605,496 shares worth $575M. The largest sale was Pfizer, an estimated $433M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 22% a quarter earlier, followed by Healthcare and Industrials.
- Boston Partners's largest Q4 2021 buy was Keurig Dr Pepper: 15,605,496 shares worth $575M.
- Boston Partners added most to Fidelity National Information Services in Q4 2021, an estimated $353M increase.
- Boston Partners's biggest Q4 2021 reduction was Pfizer, cutting an estimated $433M.
- Boston Partners fully exited CyrusOne Inc Common Stock in Q4 2021, selling an estimated $137M.
- Boston Partners's ten largest holdings make up 13% of its $83B portfolio in Q4 2021.
- Boston Partners opened 59 new positions and closed 45 in Q4 2021.
- Boston Partners's portfolio value rose 5.2% quarter-over-quarter to $83B.
Based on Boston Partners's 13F filing for Q4 2021, filed 4 Feb 2022.